⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9723039 | 0.70 | — | — | |
| SCHEMBL1618531 | 0.70 | — | — | |
| SCHEMBL23062 | 0.70 | — | — | |
| SCHEMBL23930 | 0.67 | — | — | |
| SCHEMBL8968202 | 0.67 | — | — | |
| SCHEMBL81194 | 0.67 | — | — | |
| SCHEMBL16095931 | 0.67 | — | — | |
| SCHEMBL628336 | 0.67 | — | — | |
| SCHEMBL578470 | 0.67 | — | — | |
| SCHEMBL7016685 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1627875-B1 | METHOD FOR PRODUCING CYCLIC DIAMINE DERIVATIVE OR SALT THEREOF | KOWA CO (JP) | 2013-07-31 | — | — | EP | disclosed |
| WO-2009085695-A1 | TREATMENT OR PREVENTION OF SKIN INJURY DUE TO EXPOSURE TO ULTRAVIOLET LIGHT | HORWITZ LAWRENCE D (US) | 2009-07-09 | — | — | WO | disclosed |
| US-20090169497-A1 | Treatment and Prevention of Skin Injury Due to Exposure to Ultraviolet Light | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2009-07-02 | — | — | US | disclosed |
| US-7459552-B2 | Method for producing cyclic diamine derivative or salt thereof | KOWA CO., LTD. (JP) | 2008-12-02 | — | — | US | disclosed |
| US-20060293519-A1 | Method for producing cyclic diamine derivative or salt thereof | KOWA CO., LTD. (JP) | 2006-12-28 | — | — | US | disclosed |
| EP-1627875-A1 | METHOD FOR PRODUCING CYCLIC DIAMINE DERIVATIVE OR SALT THEREOF | Kowa Co., Ltd. (JP) | 2006-02-22 | — | — | EP | disclosed |
| EP-0910355-B1 | TRAITEMENT AND PREVENTION OF ADVERSE EFFECTS OF REACTIVE OXYGEN SPECIES | UNIV COLORADO (US) | 2002-11-06 | — | — | EP | disclosed |
| EP-0798291-B1 | NOVEL 1,3-DIALKYLUREA DERIVATIVES | SANTEN PHARMACEUTICAL CO LTD (JP) | 2002-09-11 | — | — | EP | disclosed |
| EP-0738711-B1 | NOVEL 1,3-DIALKYLUREA DERIVATIVE HAVING HYDROXYL GROUP | SANTEN PHARMACEUTICAL CO LTD (JP) | 2000-03-08 | — | — | EP | disclosed |
| US-5968980-A | ENDOPEPTIDASE 24.11 INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1999-10-19 | — | — | US | disclosed |
| US-5891912-A | ENDOPEPTIDASE 24.11 INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1999-04-06 | — | — | US | disclosed |
| US-5756547-A | PREVENTING DAMAGE DUE TO REACTIVE OXYGEN SPECIES | REGENTS OF THE UNIVERSITY OF COLORADO (US) | 1998-05-26 | — | — | US | disclosed |
| EP-0798291-A1 | NOVEL 1,3-DIALKYLUREA DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1997-10-01 | — | — | EP | disclosed |
| US-5670545-A | CARDIOVASCULAR DISORDERS | BOARD OF REGENTS OF THE UNIVERSITY OF COLORADO (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0738711-A1 | NOVEL 1,3-DIALKYLUREA DERIVATIVE HAVING HYDROXYL GROUP | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1996-10-23 | — | — | EP | disclosed |